Silence Therapeutics (SLN) Receivables: 2019-2025
Historic Receivables for Silence Therapeutics (SLN) over the last 7 years, with Sep 2025 value amounting to $28,000.
- Silence Therapeutics' Receivables fell 92.52% to $28,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $28,000, marking a year-over-year decrease of 92.52%. This contributed to the annual value of $972,000 for FY2024, which is 235.17% up from last year.
- Silence Therapeutics' Receivables amounted to $28,000 in Q3 2025, which was down 67.06% from $85,000 recorded in Q2 2025.
- Silence Therapeutics' 5-year Receivables high stood at $15.4 million for Q2 2023, and its period low was $28,000 during Q3 2025.
- Moreover, its 3-year median value for Receivables was $585,208 (2023), whereas its average is $2.9 million.
- In the last 5 years, Silence Therapeutics' Receivables soared by 496.74% in 2022 and then plummeted by 99.60% in 2025.
- Silence Therapeutics' Receivables (MRQ) stood at $446,191 in 2021, then soared by 140.53% to $1.1 million in 2022, then crashed by 72.98% to $290,000 in 2023, then soared by 235.17% to $972,000 in 2024, then plummeted by 97.12% to $28,000 in 2025.
- Its last three reported values are $28,000 in Q3 2025, $85,000 for Q2 2025, and $41,000 during Q1 2025.